Recently, systemic delivery of Cdc20 siRNA by intraperitoneal injection was shown to inhibit B16F10 melanoma growth in tumor bearing mice [71, 72] and Cdc20 has been proposed as a cancer therapeutic target [72]. Here, CDC20 is linked to cancer.